LGM

Logos Global Management Portfolio holdings

AUM $749M
This Quarter Return
+61.99%
1 Year Return
+18.94%
3 Year Return
+431.72%
5 Year Return
+481.1%
10 Year Return
–
AUM
$1.15B
AUM Growth
+$1.15B
Cap. Flow
+$1.54M
Cap. Flow %
0.13%
Top 10 Hldgs %
68.94%
Holding
74
New
27
Increased
4
Reduced
18
Closed
15

Top Buys

1
OLMA icon
Olema Pharmaceuticals
OLMA
$180M
2
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
$22.7M
3
APLS icon
Apellis Pharmaceuticals
APLS
$17.2M
4
ALGS icon
Aligos Therapeutics
ALGS
$16.8M
5
CCCC icon
C4 Therapeutics
CCCC
$15.8M

Top Sells

1
KROS icon
Keros Therapeutics
KROS
$81.1M
2
GBT
Global Blood Therapeutics, Inc.
GBT
$46.9M
3
TGTX icon
TG Therapeutics
TGTX
$46.8M
4
SRPT icon
Sarepta Therapeutics
SRPT
$38.6M
5
NKTX icon
Nkarta
NKTX
$22.4M

Sector Composition

1 Healthcare 98.79%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
KALV icon
26
KalVista Pharmaceuticals
KALV
$678M
$9.31M 0.8%
490,000
+190,000
+63% +$3.61M
VRDN icon
27
Viridian Therapeutics
VRDN
$1.5B
$9.05M 0.78%
+550,000
New +$9.05M
PASG icon
28
Passage Bio
PASG
$22.7M
$8.81M 0.76%
344,438
– –
VINCU
29
DELISTED
Vincerx Pharma, Inc. Unit
VINCU
$7.7M 0.66%
+400,000
New +$7.7M
NRIX icon
30
Nurix Therapeutics
NRIX
$696M
$7.57M 0.65%
230,297
-44,703
-16% -$1.47M
PNT
31
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$6.96M 0.6%
500,000
– –
KYMR icon
32
Kymera Therapeutics
KYMR
$2.91B
$6.88M 0.59%
110,920
-190,000
-63% -$11.8M
EPIX icon
33
ESSA Pharma
EPIX
$11.3M
$6.56M 0.56%
+550,000
New +$6.56M
STTK icon
34
Shattuck Labs
STTK
$48.4M
$6.37M 0.55%
+121,562
New +$6.37M
PMVP icon
35
PMV Pharmaceuticals
PMVP
$79M
$6.15M 0.53%
100,000
-50,000
-33% -$3.08M
LUNG icon
36
Pulmonx
LUNG
$70.5M
$5.18M 0.44%
+75,000
New +$5.18M
EYPT icon
37
EyePoint Pharmaceuticals
EYPT
$797M
$4.61M 0.39%
+699,999
New +$4.61M
ANNX icon
38
Annexon
ANNX
$226M
$4M 0.34%
159,622
– –
BDTX icon
39
Black Diamond Therapeutics
BDTX
$159M
$3.96M 0.34%
123,465
– –
OBIO icon
40
Orchestra BioMed
OBIO
$147M
$3.84M 0.33%
300,000
– –
PCVX icon
41
Vaxcyte
PCVX
$4.1B
$3.72M 0.32%
+140,000
New +$3.72M
HRMY icon
42
Harmony Biosciences
HRMY
$2.13B
$3.62M 0.31%
100,000
-175,000
-64% -$6.33M
BMY.RT
43
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$3.49M 0.3%
5,050,000
-450,000
-8% -$311K
ELDN icon
44
Eledon Pharmaceuticals
ELDN
$155M
$3.45M 0.3%
+224,071
New +$3.45M
ITOS
45
DELISTED
iTeos Therapeutics
ITOS
$3.38M 0.29%
100,000
-200,000
-67% -$6.76M
OM icon
46
Outset Medical
OM
$247M
$2.84M 0.24%
50,000
-50,000
-50% -$2.84M
PANA.U
47
DELISTED
Panacea Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third
PANA.U
$2.55M 0.22%
200,000
– –
TNGX icon
48
Tango Therapeutics
TNGX
$747M
$2.29M 0.2%
200,000
– –
MLTX icon
49
MoonLake Immunotherapeutics
MLTX
$3.54B
$2.27M 0.19%
+200,000
New +$2.27M
EAR
50
DELISTED
Eargo, Inc. Common Stock
EAR
$2.24M 0.19%
+50,000
New +$2.24M
1
2
3